Latest News by Industry
Record Fiscal 2022 Revenue of $4.58 Billion, up 6.7% YoY as Reported and up 10.3% YoY in Pro Forma(2) Constant Currency(3)
Continued Sales Momentum & Record 12-Month Backlog of $3.97 Billion, up 7.6% YoY
Expects Fiscal 2023 Revenue Growth of 4.0%-8.0% YoY as Reported and 6.0%-10.0% YoY in Constant Currency(3)
Full Year Fiscal 2022 Highlights
(All comparisons are against the prior year)
Fourth Quarter Fiscal 2022 Highlights
(All comparisons are against the prior year’s fourth quarter)
JERSEY CITY, N.J., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Amdocs Limited (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today reported operating results for the fourth fiscal quarter and full fiscal year ended September 30, 2022.
“Fiscal 2022 was a landmark year for Amdocs, and I could not be prouder of our talented employees and our many amazing achievements. We delivered accelerated full year revenue growth of 10.3% on a pro forma(2) constant currency (3) basis as we executed our strategy to support the industry’s need for digital modernization, 5G monetization, cloud, and network automation with market-leading innovation. Strong sales momentum throughout fiscal 2022 continued in Q4 and included a five-year agreement to migrate Amdocs systems to the cloud for AT&T Mexico. Additionally, we are working with Rogers to move existing Amdocs services and applications to Rogers' private cloud. Overall, we ended fiscal 2022 with record-high 12-month backlog of $3.97 billion, up approximately 8% from a year ago”, said Shuky Sheffer, president and chief executive officer of Amdocs Management Limited.
“Amdocs’ reputation for project execution is unrivalled in our industry, as demonstrated by a record number of production milestones achieved for our customers in Q4 and the full 2022 fiscal year. At the same time, we maintained consistent profitability and generated robust free cash flow, primarily driven by strong levels of customer cash collections throughout the fiscal year. Fiscal year 2022 was also a record year in managed services where recent customer activity included new long-term strategic agreements that strengthen and broaden our relationships with Charter in North America, Telefonica Hispanoamerica in Argentina, Chile and Peru, and SES in Europe,” said Tamar Rapaport-Dagim, chief financial officer & chief operating officer of Amdocs Management Limited.
Sheffer concluded, “We are confident in our unique and resilient business model given the strategic and mission critical nature of our products and services that we provide under multi-year customer engagements. While we are not immune to the current macro uncertainty, our role as a trusted partner is especially valuable during such times as we work to help service providers improve customer experience, accelerate cost reduction, and increase efficiency with our digital, cloud, automation and 5G monetization capabilities. Taking everything into consideration, we are positioned to deliver fiscal year 2023 revenue growth in line with the midpoint of our long-term target range of 6% to 10% on a constant currency(3) basis while delivering strong earnings to cash conversion.”
Revenue
(All comparisons are against the prior yearperiod)
| In millions | |||||
| Three months ended | Twelve months ended | ||||
| September 30, 2022 | September 30, 2022 | ||||
| Actual | Previous Guidance | Actual | Previous Guidance | ||
| Revenue | $1,167 | $1,145 - $1,185 | $4,577 | -- | |
| Revenue growth, as reported | 7.3% | -- | 6.7% | 6.2% - 7.2% | |
| Revenue growth, constant currency(3) | 9.5% | -- | -- | -- | |
| Pro forma(2) revenue growth, constant currency(3) | -- | -- | 10.3% | 9.6% - 10.6% | |
Net Income and Earnings Per Share
| In thousands, except per share data | |||||||||||
| Three months ended | Twelve months ended | ||||||||||
| September 30, | September 30, | ||||||||||
| 2022 | 2021 | 2022 | 2021(a) | ||||||||
| GAAP Measures | |||||||||||
| Net income | $ | 128,936 | $ | 123,525 | $ | 549,501 | $ | 688,374 | |||
| Diluted earnings per share | $ | 1.05 | $ | 0.97 | $ | 4.44 | $ | 5.32 | |||
| Non-GAAP Measures | |||||||||||
| Net income | $ | 157,548 | $ | 147,470 | $ | 655,147 | $ | 621,820 | |||
| Diluted earnings per share | $ | 1.29 | $ | 1.16 | $ | 5.30 | $ | 4.81 | |||
For further details of the reconciliation of selected financial metrics from GAAP to Non-GAAP, please refer to the tables below.
Capital Allocation: Returning Cash to Shareholders
Twelve-month Backlog
Twelve-month backlog was a record $3.97 billion at the end of the fourth quarter of fiscal 2022, up approximately 7.6% as compared to last year’s fourth fiscal quarter. Twelve-month backlog includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities.
First Quarter Fiscal 2023 Outlook
| In millions, except per share data | |
| Q1 2023 | |
| Revenue | $1,155-$1,195 |
| GAAP diluted EPS | $1.00-$1.08 |
| Non-GAAP diluted EPS | $1.29-$1.35 |
Full Year Fiscal 2023 Outlook
| FY 2023, year-over-year growth | |
| Revenue growth, as reported | 4.0%-8.0% |
| Revenue growth, constant currency(3) | 6.0%-10.0% |
| GAAP diluted EPS growth | 3.0% - 10.0% |
| Non-GAAP diluted EPS growth | 8.0%-12.0% |
| In millions | |
| FY 2023, | |
| Free cash flow(1) | ~$700 |
The forward looking statements regarding our first fiscal quarter 2023 and full year fiscal 2023 guidance take into consideration the Company’s current expectations regarding macro and industry specific risks and various uncertainties and certain assumptions that we will discuss on our earnings conference call. However, we note that market dynamics continue to shift rapidly and we cannot predict all possible outcomes, including those resulting from certain geopolitical events, the current inflationary environment, the COVID-19 pandemic and the prevailing level of macro-economic, business and operational uncertainty, which have created, and continues to create, a significant amount of uncertainty, or from current and potential customer consolidation or their other strategic corporate activities.
Conference Call and Earnings Webcast Presentation Details
Amdocs will host a conference call and earnings webcast presentation on November 8, 2022 at 5:00 p.m. Eastern Time to discuss the Company's fourth quarter of fiscal 2022 results.
To participate in the call, please register here to receive the dial-in numbers and unique access PIN. The conference call and webcast will also be carried live on the Internet and may be accessed via the Amdocs website at https://investors.amdocs.com. Presentation slides will be available shortly before the webcast.
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow and normalized free cash flow, revenue on a constant currency(3) basis, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth. These other non-GAAP measures exclude the following items:
Free cash flow equals cash generated by operating activities less net capital expenditures and other. Normalized free cash flow, a measure of our operating performance, is further adjusted to exclude net capital expenditures related to the new campus development, payments for non-recurring and unusual charges (such as capital gains tax in relation to the divestiture of OpenMarket), and payments of acquisition related liabilities. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.
Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow and normalized free cash flow, non-GAAP cost of revenue, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expenses, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP diluted earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.
For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition-related costs, changes in certain acquisition-related liabilities measured at fair value, non-recurring and unusual charges or benefits, equity-based compensation expense, other and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.
Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of revenue, research and development, selling, general and administrative, operating income, interest and other expenses, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.
Supporting Resources
About Amdocs
Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers’ innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and large enterprise customers. Our 31,000 employees around the globe are here to accelerate service providers’ migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $4.58 billion in fiscal 2022.
For more information, visit Amdocs at www.amdocs.com.
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of macro-economic conditions, including as a result of geopolitical events or other global or regional events such as the COVID-19 pandemic, as well as the current inflationary environment, and the effects of these conditions on the company’s clients’ businesses and levels of business activity, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs’ filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2021 filed on December 9, 2021 and our Form 6-K furnished for the first quarter of fiscal 2022 on February 14, 2022, the second quarter of fiscal 2022 on May 24, 2022 and for the third quarter of fiscal 2022 on August 15, 2022.
.
Contact:
Matthew Smith
Head of Investor Relations
Amdocs
314-212-8328
E-mail: dox_info@amdocs.com
| AMDOCS LIMITED Consolidated Statements of Income (In thousands, except per share data) | ||||||||||||||||
| Three months ended | Fiscal year ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021(a) | |||||||||||||
| Revenue | $ | 1,166,504 | $ | 1,087,309 | $ | 4,576,697 | $ | 4,288,640 | ||||||||
| Operating expenses: | ||||||||||||||||
| Cost of revenue | 751,358 | 707,366 | 2,957,547 | 2,810,967 | ||||||||||||
| Research and development | 96,218 | 81,324 | 354,706 | 312,941 | ||||||||||||
| Selling, general and administrative | 129,404 | 126,015 | 528,572 | 487,255 | ||||||||||||
| Amortization of purchased intangible assets and other | 17,838 | 18,274 | 71,075 | 78,784 | ||||||||||||
| 994,818 | 932,979 | 3,911,900 | 3,689,947 | |||||||||||||
| Operating income | 171,686 | 154,330 | 664,797 | 598,693 | ||||||||||||
| Interest and other expense, net | (7,399 | ) | (1,099 | ) | (26,391 | ) | (10,797 | ) | ||||||||
| Gain from sale of a business | - | - | 10,000 | 226,410 | ||||||||||||
| Income before income taxes | 164,287 | 153,231 | 648,406 | 814,306 | ||||||||||||
| Income taxes | 35,351 | 29,706 | 98,905 | 125,932 | ||||||||||||
| Net income | $ | 128,936 | $ | 123,525 | $ | 549,501 | $ | 688,374 | ||||||||
| Basic earnings per share | $ | 1.06 | $ | 0.98 | $ | 4.47 | $ | 5.36 | ||||||||
| Diluted earnings per share | $ | 1.05 | $ | 0.97 | $ | 4.44 | $ | 5.32 | ||||||||
| Basic weighted average number of shares outstanding | 121,449 | 125,923 | 122,812 | 128,495 | ||||||||||||
| Diluted weighted average number of shares outstanding | 122,320 | 126,820 | 123,650 | 129,284 | ||||||||||||
| Cash dividends declared per share | $ | 0.395 | $ | 0.36 | $ | 1.545 | $ | 1.4075 | ||||||||
| AMDOCS LIMITED Selected Financial Metrics (In thousands, except per share data) | ||||||||||||||||
| Three months ended | Fiscal year ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021(a) | |||||||||||||
| Revenue | $ | 1,166,504 | $ | 1,087,309 | $ | 4,576,697 | $ | 4,288,640 | ||||||||
| Non-GAAP operating income | 205,337 | 190,195 | 804,894 | 750,665 | ||||||||||||
| Non-GAAP net income | 157,548 | 147,470 | 655,147 | 621,820 | ||||||||||||
| Non-GAAP diluted earnings per share | $ | 1.29 | $ | 1.16 | $ | 5.30 | $ | 4.81 | ||||||||
| Diluted weighted average number of shares outstanding | 122,320 | 126,820 | 123,650 | 129,284 | ||||||||||||
| Free Cash Flows and Normalized Free Cash Flow (In thousands) | ||||||||||||||||
| Three months ended | Fiscal year ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021(a) | |||||||||||||
| Net Cash Provided by Operating Activities | $ | 216,919 | $ | 199,713 | $ | 756,719 | $ | 925,807 | ||||||||
| Purchases of property and equipment, net(c) | (81,819 | ) | (60,873 | ) | (227,219 | ) | (210,438 | ) | ||||||||
| Free Cash Flow | 135,100 | 138,840 | 529,500 | 715,369 | ||||||||||||
| Tax payment on sale of business(b) | - | 809 | 3,193 | 39,596 | ||||||||||||
| Payments of acquisition related liabilities | 1,925 | - | 16,275 | 13,234 | ||||||||||||
| Net capital expenditures related to the new campus development | 38,683 | 32,801 | 116,359 | 100,680 | ||||||||||||
| Normalized Free Cash Flow | $ | 175,708 | $ | 172,450 | $ | 665,327 | $ | 868,879 | ||||||||
| (a) Since January 1, 2021, OpenMarket results are not included in the Consolidated Statements of Income given its divestiture. | ||||||||||||||||
| (b) Tax payment related to capital gain from divestiture of OpenMarket, which was completed on December 31, 2020. | ||||||||||||||||
| (c) The amounts under "Purchase of property and equipment, net” include proceeds from sale of property and equipment of $521 and $328 for the Fiscal years ended September 30, 2022 and 2021, respectively. | ||||||||||||||||
| AMDOCS LIMITED Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP (In thousands) | |||||||||||||||||||||
| Three months ended September 30, 2022 | |||||||||||||||||||||
| Reconciliation items | |||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other | Equity based compensation expense | Changes in certain acquisitions related liabilities measured at fair value | Other | Tax effect | Non-GAAP | |||||||||||||||
| Operating expenses: | |||||||||||||||||||||
| Cost of revenue | $ | 751,358 | $ | - | $ | (8,356 | ) | $ | 3,294 | $ | - | $ | - | $ | 746,296 | ||||||
| Research and development | 96,218 | (1,538 | ) | 94,680 | |||||||||||||||||
| Selling, general and administrative | 129,404 | (9,213 | ) | 120,191 | |||||||||||||||||
| Amortization of purchased intangible assets and other | 17,838 | (17,838 | ) | - | |||||||||||||||||
| Total operating expenses | 994,818 | (17,838 | ) | (19,107 | ) | 3,294 | - | - | 961,167 | ||||||||||||
| Operating income | 171,686 | 17,838 | 19,107 | (3,294 | ) | 205,337 | |||||||||||||||
| Interest and other expense, net | (7,399 | ) | 400 | (6,999 | ) | ||||||||||||||||
| Income taxes | 35,351 | 5,439 | 40,790 | ||||||||||||||||||
| Net income | $ | 128,936 | $ | 17,838 | $ | 19,107 | $ | (3,294 | ) | $ | 400 | $ | (5,439 | ) | $ | 157,548 | |||||
| Three months ended September 30, 2021 | |||||||||||||||||||||
| Reconciliation items | |||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other | Equity based compensation expense | Changes in certain acquisitions related liabilities measured at fair value | Other | Tax effect | Non-GAAP | |||||||||||||||
| Operating expenses: | |||||||||||||||||||||
| Cost of revenue | $ | 707,366 | $ | - | $ | (6,148 | ) | $ | (3,285 | ) | $ | - | $ | - | $ | 697,933 | |||||
| Research and development | 81,324 | - | (1,145 | ) | - | - | - | 80,179 | |||||||||||||
| Selling, general and administrative | 126,015 | - | (7,013 | ) | - | - | - | 119,002 | |||||||||||||
| Amortization of purchased intangible assets and other | 18,274 | (18,274 | ) | - | - | - | - | - | |||||||||||||
| Total operating expenses | 932,979 | (18,274 | ) | (14,306 | ) | (3,285 | ) | - | - | 897,114 | |||||||||||
| Operating income | 154,330 | 18,274 | 14,306 | 3,285 | - | - | 190,195 | ||||||||||||||
| Interest and other expense, net | (1,099 | ) | - | - | - | (4,360 | ) | - | (5,459 | ) | |||||||||||
| Income taxes | 29,706 | - | - | - | - | 7,560 | 37,266 | ||||||||||||||
| Net income | $ | 123,525 | $ | 18,274 | $ | 14,306 | $ | 3,285 | $ | (4,360 | ) | $ | (7,560 | ) | $ | 147,470 | |||||
| AMDOCS LIMITED Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP (In thousands) | ||||||||||||||||||||||||
| Fiscal year ended | ||||||||||||||||||||||||
| September 30, 2022 | ||||||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other | Equity based compensation expense | Changes in certain acquisitions related liabilities measured at fair value | Gain from sale of a business | Other | Tax effect | Non-GAAP | |||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||
| Cost of revenue | $ | 2,957,547 | $ | - | $ | (32,096 | ) | $ | 2,785 | $ | - | $ | - | $ | - | $ | 2,928,236 | |||||||
| Research and development | 354,706 | (5,631 | ) | 349,075 | ||||||||||||||||||||
| Selling, general and administrative | 528,572 | (34,080 | ) | 494,492 | ||||||||||||||||||||
| Amortization of purchased intangible assets and other | 71,075 | (71,075 | ) | - | ||||||||||||||||||||
| Total operating expenses | 3,911,900 | (71,075 | ) | (71,807 | ) | 2,785 | - | - | 3,771,803 | |||||||||||||||
| Operating income | 664,797 | 71,075 | 71,807 | (2,785 | ) | - | 804,894 | |||||||||||||||||
| Interest and other expense, net | (26,391 | ) | (1,605 | ) | (27,996 | ) | ||||||||||||||||||
| Gain from sale of a business | 10,000 | (10,000 | ) | - | ||||||||||||||||||||
| Income taxes | 98,905 | 22,846 | 121,751 | |||||||||||||||||||||
| Net income | $ | 549,501 | $ | 71,075 | $ | 71,807 | $ | (2,785 | ) | $ | (10,000 | ) | $ | (1,605 | ) | $ | (22,846 | ) | $ | 655,147 | ||||
| Fiscal year ended | ||||||||||||||||||||||||
| September 30, 2021(a) | ||||||||||||||||||||||||
| Reconciliation items | ||||||||||||||||||||||||
| GAAP | Amortization of purchased intangible assets and other | Equity based compensation expense | Changes in certain acquisitions related liabilities measured at fair value | Gain from sale of a business | Other | Tax effect | Non-GAAP | |||||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||
| Cost of revenue | $ | 2,810,967 | $ | - | $ | (22,691 | ) | $ | (18,939 | ) | $ | - | $ | - | $ | - | $ | 2,769,337 | ||||||
| Research and development | 312,941 | - | (4,021 | ) | - | - | - | - | 308,920 | |||||||||||||||
| Selling, general and administrative | 487,255 | - | (27,537 | ) | - | - | - | - | 459,718 | |||||||||||||||
| Amortization of purchased intangible assets and other | 78,784 | (78,784 | ) | - | - | - | - | - | - | |||||||||||||||
| Total operating expenses | 3,689,947 | (78,784 | ) | (54,249 | ) | (18,939 | ) | - | - | - | 3,537,975 | |||||||||||||
| Operating income | 598,693 | 78,784 | 54,249 | 18,939 | - | - | - | 750,665 | ||||||||||||||||
| Interest and other expense, net | (10,797 | ) | - | - | - | - | (5,046 | ) | - | (15,843 | ) | |||||||||||||
| Gain from sale of a business | 226,410 | - | - | - | (226,410 | ) | - | - | - | |||||||||||||||
| Income taxes | 125,932 | - | - | - | - | - | (12,930 | ) | 113,002 | |||||||||||||||
| Net income | $ | 688,374 | $ | 78,784 | $ | 54,249 | $ | 18,939 | $ | (226,410 | ) | $ | (5,046 | ) | $ | 12,930 | $ | 621,820 | ||||||
| AMDOCS LIMITED Condensed Consolidated Balance Sheets (In thousands) | ||||||||
| As of | ||||||||
| September 30, 2022 | September 30, 2021 | |||||||
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | $ | 573,377 | $ | 709,064 | ||||
| Short-term interest-bearing investments | 244,603 | 256,527 | ||||||
| Accounts receivable, net, including unbilled of $157,165 and $162,278, respectively | 946,777 | 866,819 | ||||||
| Prepaid expenses and other current assets | 238,390 | 235,089 | ||||||
| Total current assets | 2,003,147 | 2,067,499 | ||||||
| Property and equipment, net | 794,287 | 698,768 | ||||||
| Lease assets | 176,884 | 233,162 | ||||||
| Goodwill and other intangible assets, net | 2,841,137 | 2,881,676 | ||||||
| Other noncurrent assets | 574,938 | 630,669 | ||||||
| Total assets | $ | 6,390,393 | $ | 6,511,774 | ||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
| Current liabilities | ||||||||
| Accounts payable, accruals and other | $ | 955,658 | $ | 1,007,777 | ||||
| Lease liabilities | 43,336 | 58,714 | ||||||
| Deferred revenue | 253,686 | 237,374 | ||||||
| Total current liabilities | 1,252,680 | 1,303,865 | ||||||
| Lease liabilities | 138,378 | 177,906 | ||||||
| Long-term debt, net of unamortized debt issuance costs | 645,117 | 644,553 | ||||||
| Other noncurrent liabilities | 793,940 | 750,266 | ||||||
| Total Amdocs Limited Shareholders’ equity | 3,517,769 | 3,592,675 | ||||||
| Noncontrolling interests | 42,509 | 42,509 | ||||||
| Total equity | 3,560,278 | 3,635,184 | ||||||
| Total liabilities and equity | $ | 6,390,393 | $ | 6,511,774 | ||||
| AMDOCS LIMITED Consolidated Statements of Cash Flows (In thousands) | ||||||||
| Fiscal year ended September 30, | ||||||||
| 2022 | 2021(a) | |||||||
| Cash Flow from Operating Activities: | ||||||||
| Net income | $ | 549,501 | $ | 688,374 | ||||
| Reconciliation of net income to net cash provided by operating activities: | ||||||||
| Depreciation, amortization and impairment | 224,535 | 208,830 | ||||||
| Amortization of debt issuance costs | 564 | 548 | ||||||
| Equity-based compensation expense | 71,807 | 54,249 | ||||||
| Gain from sale of a business | (10,000 | ) | (226,410 | ) | ||||
| Deferred income taxes | (3,292 | ) | (50,605 | ) | ||||
| Loss from short-term interest-bearing investments | 2,728 | 1,726 | ||||||
| Net changes in operating assets and liabilities, net of amounts acquired: | ||||||||
| Accounts receivable, net | (64,978 | ) | (69,051 | ) | ||||
| Prepaid expenses and other current assets | (3,527 | ) | (17,041 | ) | ||||
| Other noncurrent assets | 19,760 | (50,038 | ) | |||||
| Lease assets and liabilities, net | 1,394 | 9,630 | ||||||
| Accounts payable, accrued expenses and accrued personnel | (83,932 | ) | 122,224 | |||||
| Deferred revenue | (22,456 | ) | 193,655 | |||||
| Income taxes payable, net | 15,648 | 26,814 | ||||||
| Other noncurrent liabilities | 58,967 | 32,902 | ||||||
| Net cash provided by operating activities | 756,719 | 925,807 | ||||||
| Cash Flow from Investing Activities: | ||||||||
| Purchase of property and equipment, net(c) | (227,219 | ) | (210,438 | ) | ||||
| Proceeds from sale of short-term interest-bearing investments | 21,948 | 18,205 | ||||||
| Purchase of short-term interest-bearing investments | (34,275 | ) | (276,978 | ) | ||||
| Net cash paid for business and intangible assets acquisitions | (24,430 | ) | (142,697 | ) | ||||
| Net cash received from sale of a business | 10,000 | 288,990 | ||||||
| Other | (8,525 | ) | (6,082 | ) | ||||
| Net cash used in investing activities | (262,501 | ) | (329,000 | ) | ||||
| Cash Flow from Financing Activities: | ||||||||
| Payments under financing arrangements | - | (100,000 | ) | |||||
| Repurchase of shares | (508,472 | ) | (679,996 | ) | ||||
| Proceeds from employee stock options exercises | 82,924 | 89,056 | ||||||
| Payments of dividends | (186,073 | ) | (177,472 | ) | ||||
| Payment of contingent consideration from a business acquisition | (18,284 | ) | (2,519 | ) | ||||
| Net cash used in financing activities | (629,905 | ) | (870,931 | ) | ||||
| Net decrease in cash and cash equivalents | (135,687 | ) | (274,124 | ) | ||||
| Cash and cash equivalents at beginning of period | 709,064 | 983,188 | ||||||
| Cash and cash equivalents at end of period | $ | 573,377 | $ | 709,064 | ||||
| AMDOCS LIMITED Supplementary Information (In millions) | |||||||||||||||
| Three months ended | |||||||||||||||
| September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | |||||||||||
| North America | $ | 794.4 | $ | 788.0 | $ | 772.2 | $ | 745.5 | $ | 722.8 | |||||
| Europe | 146.4 | 146.1 | 147.2 | 142.5 | 146.8 | ||||||||||
| Rest of the World | 225.7 | 226.2 | 225.9 | 216.6 | 217.7 | ||||||||||
| Total Revenue | $ | 1,166.5 | $ | 1,160.3 | $ | 1,145.3 | $ | 1,104.6 | $ | 1,087.3 | |||||
| Three months ended | |||||||||||||||
| September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | |||||||||||
| Managed Services Revenue | $ | 714.6 | $ | 717.9 | $ | 663.4 | $ | 659.7 | $ | 637.5 | |||||
| As of | |||||||||||||||
| September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | |||||||||||
| 12-Month Backlog | $ | 3,970 | $ | 3,950 | $ | 3,890 | $ | 3,830 | $ | 3,690 | |||||
(1) Please refer to the Selected Financial Metrics tables (figures may not sum because of rounding).
(2) Pro forma growth rate excludes the financial impact of OpenMarket (which was divested on December 31, 2020) from fiscal year 2021
(3) Revenue on a constant currency basis assumes exchange rates in the current period were unchanged from the prior period
(4) Adjusted GAAP excludes the gain from the sale of OpenMarket, which was divested on December 31, 2020, from the current and comparable fiscal years